The present study aimed to investigate the age- and sex-related differences in the associations of serum osteocalcin concentrations with cardiometabolic risk factors, such as markers of glycemic control, HbA1C, FBG, lipid profiles, obesity, and MetS in patients with T2D. This evidence concerns the gene BGLAP and metabolic syndrome.